Pages
Dr Chris Clayton appointed as Chief Executive Designate JUCD
The appointment of Dr Chris Clayton as Chief Executive Designate of the NHS Integrated Care Board for Derby and Derbyshire.
Health Psychology
The DCHS health psychology service provides specialist psychological care and support to adults with physical health problems.
https://dchs.nhs.uk/our-services-and-locations/a-z-list-of-services/health-psychology
Contractor appointed to build new £15m health services hub for Belper
https://dchs.nhs.uk/news/contractor-appointed-build-new-15m-health-services-hub-belper
Top tips for saving on energy bills
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/top-tips-saving-energy-bills
October is AAC Awareness Month!
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/october-aac-awareness-month
Sustainability/Green Agenda
https://dchs.nhs.uk/my_dchs/i-want-more-information-on/corporate-services/sustainabilitygreen-agenda
Have you got an NHS workforce story to tell?
https://dchs.nhs.uk/news/have-you-got-nhs-workforce-story-tell
Improvement, Innovation and Effectiveness
Supporting colleagues to keep DCHS an outstanding place to work and recive care.
https://dchs.nhs.uk/about-us/quality-heart-our-care/improvement-innovation-effectiveness
Files
Clinical Harms Review Additional detail for Service Level SOP (S130)
This document should be read in conjunction with the overarching DCHS Standard Operating procedure on Clinical Harms which outlines the processes to be followed to deliver a consistent approach to: • Utilising a proactive method of risk stratification to minimise clinical harm as a result of delays in care. • Embedding systems which consider health inequalities. • Monitoring waiting times against defined thresholds across pathways of care. • Delivering personalised, patient-centred communications to patients who are waiting for care. • Implementing Harm Reviews for the that support the Trusts governance and assurance processes and maintains practice in line with national expectations.
Patient (or carer) Initiated Follow-up SOP Dementia Palliative Care Service (S132)
Patient initiated follow-up (PIFU) describes when a patient (or their carer) can initiate their follow-up visit as and when required, e.g., when symptoms or circumstances change. This SOP defines the process, roles, and responsibilities for the following: • Identifying which patients PIFU is right for • Moving a patient onto a PIFU pathway • Booking visits which have been initiated by a patient or carer • Managing patients who do not initiate a review/home visit within the PIFU timescale • Discharging or booking reviews at the end of that patient’s PIFU timescale • Monitoring compliance Dementia Palliative Care Service are in the process of piloting a PIFU process for 12 months. The pilot will be reviewed every 3 months with a final review post 12 months.
Disclosure Ref 202529 - Car parking management .pdf
Disclosure to freedom of information request regarding Car Parks that are on DCHS owned sites
Disclosure Ref 202515 - Human Albumin purchased.pdf
Disclosure to freedom of information request regarding Human Albumin purchased 2023 and 2024
Disclosure Ref 202536 - Missed hospital appointments in Trust during 2024..pdf
Disclosure to freedom of information request regarding scheduled appointments were missed by patients (DNA/Did Not Attend) across all major hospitals
Disclosure Ref 202512 - Parking fines at St Oswalds.pdf
Freedom of information disclosure ref 202512 relating to parking fines at St Oswalds
Disclosure Ref 202567 - NHS hospital at home or virtual ward.pdf
Freedom of information final disclosure reference 202567 relating to NHS hospital at home or virtual ward
Disclosure Ref 202589 - Staff details for IT, Digital and informatics.pdf
Freedom of information final disclosure reference 202589 relating to staff details for IT, Digital and informatics
Disclosure Ref 2025121 - IT infrastructure and print services.pdf
Freedom of Information Disclosure Ref 2025121 relating to IT infrastructure and print services
Disclosure Ref 2025139 - Prescribed cannabis-based medicinal products.pdf
FOI Disclosure Ref 2025139 regarding the total number of individuals that were prescribed cannabis based medicinal products by the Trust